Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - Net
Ratios

Tandem Diabetes Care (TNDM) Leases (2019 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Leases for 7 consecutive years, with $98.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Leases rose 12.55% year-over-year to $98.4 million, compared with a TTM value of $98.4 million through Sep 2025, up 12.55%, and an annual FY2024 reading of $85.3 million, down 2.83% over the prior year.
  • Leases was $98.4 million for Q3 2025 at Tandem Diabetes Care, roughly flat from $98.4 million in the prior quarter.
  • Across five years, Leases topped out at $126.7 million in Q2 2022 and bottomed at $15.1 million in Q1 2021.
  • Average Leases over 5 years is $83.4 million, with a median of $89.4 million recorded in 2023.
  • The sharpest move saw Leases skyrocketed 1249.23% in 2021, then dropped 28.12% in 2023.
  • Year by year, Leases stood at $27.5 million in 2021, then soared by 302.23% to $110.6 million in 2022, then decreased by 20.64% to $87.8 million in 2023, then dropped by 2.83% to $85.3 million in 2024, then increased by 15.31% to $98.4 million in 2025.
  • Business Quant data shows Leases for TNDM at $98.4 million in Q3 2025, $98.4 million in Q2 2025, and $101.0 million in Q1 2025.